Pioneering
the Future of
Cellular Therapy
Transforming healthcare through cutting-edge cellular therapy solutions. We deliver innovative treatments backed by rigorous scientific research.
Exosome biotech company
The most promising exosome therapeutics ever for digestive tissue healing and organ regeneration.
A key asset to the future health of an ageing population
Extracellular vesicles (EVs) or exosomes are subcellular entities released by cells. It is becoming widely known that exosomes are as effective as cell therapies for tissue regeneration, diseases such as stroke, heart failure, arthritis while being safer and more convenient for supply chains. Therefore, they are increasingly explored by many stakeholders.
TheraExo mission: Unlocking the exosome revolution
Exosomes are biological nanoparticles secreted by cells with a potent role in intercellular communication. They hold promising properties for treating a wide range of diseases with high unmet medical need. Our innovation platform covers the value chain: cell sourcing, exosome generation, exosome loading, and formulation—enabling proprietary products and partnering programs.
An ambitious pipeline
Two drug candidates are under development: one for digestive tissue healing (e.g., Crohn’s fistula) and another focusing on organ regeneration (liver and kidney). Preclinical results demonstrate accelerated healing and reduced inflammation and fibrosis.
Latest news
Winner of the European EIC Accelerator program — funding to transfer EV biomanufacturing technology for first clinical grade batch production and to scale up for Phase 2/3 readiness.
TheraExo mission: Unlocking the exosome revolution
We are a pioneering biotechnology company dedicated to advancing cellular therapy through innovative research and clinical excellence. Our mission is to transform patient care with scientifically validated cellular treatments.
An innovation platform
Founded in 2025, TheraExo stands among the pioneers in exosome-based therapies, a significant revolution in the current therapeutic landscape of gene and cell therapies. Exosomes are biological nanoparticles secreted by cells that currently raise growing interest within the pharmaceutical industry due to their potent role in intercellular communication. They hold promising properties for treating a wide range of diseases with high unmet medical need. Winner of the European EIC Accelerator Program, TheraExo aims to become the leading biotech in this field.
The company has successfully developed an innovation platform protected by several patents, covering the entire technological value chain: cell sourcing, exosome generation, exosome loading, and formulation. By leveraging its platform, TheraExo aims to develop a pipeline of proprietary products in regenerative medicine, while establishing co-development partnerships in other therapeutic areas.
What our customer are saying
Mark Wanner
mark@gmail.com
“Our dedicated patient engagement app and web portal allow you to access information instantaneously (no tedeous form, long calls, or administrative hassle) and securely”
What our customer are saying
Mark Wanner
mark@gmail.com
“Our dedicated patient engagement app and web portal allow you to access information instantaneously (no tedeous form, long calls, or administrative hassle) and securely”
What our customer are saying
Mark Wanner
mark@gmail.com
“Our dedicated patient engagement app and web portal allow you to access information instantaneously (no tedeous form, long calls, or administrative hassle) and securely”
Check out our latest article
Disease detection, check up in the laboratory
In this case, the role of the health laboratory is very important to do a disease detection...
Read more
Herbal medicines that are safe for consumption
Herbal medicine is very widely used at this time because of its very good for your health...
Read more
Herbal medicines that are safe for consumption
Herbal medicine is very widely used at this time because of its very good for your health...
Read more